Systemic hypertension often leads to left ventricular hypertrophy, congestive heart failure and death (Kannel WB, et al. 1972) .
INTRODUCTION
Left atrial enlargement (LAE) is risk factor for paroxysmal supraventricular embolism and death (Jessup M, et al 2007; Aurigemma GP, et al 2004; Zile MR, et al 2004) . Left atrial size is regarded as reflection of the average effect of left ventricular filling pressure against the LA over time. And has been proposed as marker of diastolic burden (Douglas PS 2003) . In addition increased LV filling pressure resulting from disease in myocardial contractility or impairment of myocardial relaxation is considered the main pathophysioligical factor involved in heart failure and contribute to enlargement of the LA (Tsang SM, et al 2002).
OBJECTIVE
The present study is to investigate the prevalence of increase LA volume in patients with essential HTN and to assess the relationship between increase LA volume and HFnEF.
METHOD
This is case control study of 52 patients, 26 patient with history of hypertension (case subject) and 26 without history of hypertension (control subject), data were collected through interview cases and controls, physical examination done by the study physician.
Patients were included if they were older than 18 year fulfilled the diagnostic criteria of hypertension (Mancia G, et al 2013 Based on the suggestion of et al. 1986 ), the following equation was applied to determine the LV mass in gram, where the mass can be determined from short-axis dimension using simple geometric cubic formula without measuring the major axis of LV. LV mass = 0.8x1.04 [(LVID + PWT + IVST)³ -LVID³] + 0.6 Where LVID is the LV internal dimension, PWT is the posterior wall thickness, and IVST is the inter ventricular thickness. The LV mass index was obtained by dividing the LV mass by the body surface area. Left atrial volume was measured using the modified Simpsons method, maximum LA area, except for the confluence of pulmonary veins and the LA appendage were traced in apical 2and 4chamber view at end systole of the LV. LAVI was calculated as LA volume/ body surface area (Lang RM, et al 2005). Other various risk factor: BP measurement in the right arm, cigarette smoking to be quantified based on daily consumption and duration of smoking. Blood biochemistry analysis was made; FBS, cholesterol, LDL, HDL, TG, CBC STATISTICAL ANALYSIS: Was performed by using SPSS software (Version 12) difference among groups was analyzed by (t-test) and P value 0.05 was considerable significant. Mitral peak E velocity of mitral inflow, E/A ratio and deceleration were significantly greater in the hypertensive group than in control group (89.7±25 vs 72.3±17, P <0.0010.9 ±0.3 vs 1.2±0.4, P< 0.001 201±49 vs 239±42, P < 0.001 respectively).
RESULT

Table1. Comparison of clinical characteristic between patient with and without hypertension
Peak A velocity of mitral inflow was not significantly different between the two groups.
DISCUSSION
The present study demonstrated that LAV, LAVI, LVM, LVMI were increase significantly in hypertensive group compared with control group. In accordance with our study, a recent meta-analysis reported that the prevalence of left ventricle hypertrophy was greater in patients with LA enlargement than those without (Lee KS, et al 2007) . (Dreslinski GR, et al 1981) demonstrated reduced left atria emptying index as assisted by M-mode echocardiography in hypertensive patients without ECG evidence of left atrial or left ventricle enlargement, but their patients did have significantly higher echocardiographic left ventricle mass compared to control group.
The present study demonstrated that mitral peak E velocity of mitral inflow, E/A ratio and deceleration time were significantly greater in hypertensive group than in control group, which was consistent with previous studies ( found that the higher LA volume index in HFnEF with the diastolic wall strain ≤ 0.03 might be a useful marker for assessing LV diastolic function. Moreover, in the strong heart study (Kizer JR, et al 2006) , LA diameter was proved to be independent predictor of incident cardiovascular events. This relationship may be explained by several potential mechanisms firstly function of LA and ventricle are known to be interactional during the LV systolic phase, the LA acts as reservoir , while in early LV diastolic, the LA works as conduit for the influx of blood to the left ventricle .Consequently , LA contracts for LV filling in late diastolic phase thus , it is credible that increase LA size plays important role in the development of LV diastolic dysfunction (Russo C ,et al 2012 ; Lee JS ,et al 2012) . The European association of echocardiography had already included LA volume index into the diagnostic criteria of diastolic heart failure (Kindermann M, et al 2007) . In our study there was no difference in the mean age between two groups. Some studies (Gardin JM, et al 1979; Triposkidis F, et al 1995) reported that the LA size would naturally increased with age. These observations are supported by evidence that 70% of patients with atrial fibrillation are 65 year or older (Benjamin ET, et al 1994). Therefore senescence can cause alteration that would eventually culminate with LA dilation and dysfunction, thus increasing the predisposition to atrial arrhythmias (Gosselink AT, et al 1993) . However these studies utilized M-mode derived parameter to evaluate atrial dimension, which is technique that has been shown to be geometrically less exact. (Thomas L, et al 2002) and did not find variation in LAV produced by aging when utilizing Simpsons method, thus suggesting that the confirmation of LA enlargement indicates a pathological manifestation, and no a physiological aging process.
CONCLUSION
Early detection of LA enlargement may identify patients at higher cardiovascular risk and promote appropriate prevention strategies. The finding in our study indicate that echocardiography assessment is simple, non invasive, safe and easily available tool to identify asymptomatic hypertensive patients who have left ventricle hypertrophy, left atrial enlargement, left ventricle diastolic dysfunction before abnormalities detected by clinical examination.
